
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : VB-1197
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : VectivBio
Deal Size : Undisclosed
Deal Type : Acquisition
VectivBio Announces Closing of Comet Therapeutics Acquisition
Details : The acquisition of the CoMET platform significantly enhances and expands VectivBio’s pipeline including VB-1197, being evaluated in methylmalonic acidemia (MMA) and propionic acidemia (PA), two organic acidemias result in severe neurological disability...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 21, 2021
Lead Product(s) : VB-1197
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : VectivBio
Deal Size : Undisclosed
Deal Type : Acquisition
